DNA topoisomerases are one of the major molecular targets of
anticancer drugs due to the essential role of these enzymes in
rapidly proliferating cells that triggers a series of cellular events,
inducing apoptosis and finally causing cell death. In particular, topo
II inhibitors are among the most effective anticancer drugs currently
used in clinical practice